(PDF) Assessment of a New ROS1 Immunohistochemistry Clone

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Non-Small Cell Lung Carcinoma Patients: The ROSING Study

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2019.07.005

Full Text

Open PDF

Abstract

Available in full text

Date

December 1, 2019

Authors

Jose Luis Gonzalez-Larriba

Lidia Atienza-Cuevas

Esperanza Arriola-Arellano

Ihab Abdulkader

Jorge Garcia-Gonzalez

Carmen Camacho

Delvys Rodriguez-Abreu

Cristina Teixido

Noemi Reguart

Ana Gonzalez-Piñeiro

Martin Lazaro-Quintela

Isabel Esteban-Rodriguez

Publisher

Elsevier BV

Amanote Research

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Non-Small Cell Lung Carcinoma Patients: The ROSING Study

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2019.07.005

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

P1.09-09 Evaluation of a Novel ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in NSCLC Patients

ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer

P2.09-13 Correlation of ROS1 (SP384) Immunohistochemistry With ROS1 Rearrangement Determined by Fluorescence in Situ Hybridization

Clinicopathological Characteristics and Survival of ALK, ROS1 and RET Rearrangements in Non-Adenocarcinoma Non-Small Cell Lung Cancer Patients

MA26.07 ROS1 (SP384) Immunohistochemistry Inter-Reader Precision Between 12 Pathologists

Prevalence of ROS1 Fusion in Chinese Patients With Non-Small Cell Lung Cancer

ROS1 Rearrangements Are Only Found in Lung Adenocarcinomas With Diffuse Strong IHC Expression of ROS1

P2.01-50 Thromboembolism in ROS1 Rearranged Non-Small Cell Lung Cancer

Crizotinib Improves Osteoarthritis Symptoms in a ROS1-Fusion Advanced Non–Small Cell Lung Cancer Patient